Red-light therapy for dry age-related macular degeneration
Part of Eyes & vision clinical trials.
This study tests whether low-level red-light therapy can help people with dry age-related macular degeneration (AMD), a common cause of vision loss in older adults. The therapy is a painless light treatment that you might receive in multiple sessions, and the study aims to see if it can slow or improve vision decline.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 50 years old or older.
- You have been diagnosed with dry age-related macular degeneration (AMD) in at least one eye, and it is not the 'wet' type.
- Your vision should be between 20/32 and 20/100 in the affected eye, as measured by a standard eye chart.
- You have not had eye surgery (like cataract removal) in the last 3 months.
- You do not have other serious eye conditions that affect vision, such as severe glaucoma, diabetes-related eye disease, or advanced cataracts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special low-level laser treatment (photobiomodulation) can help people with an early form of age-related macular degeneration called reticular pseudodrusen. It may slow vision loss or protect your eyes from getting worse.
This trial tests a new stem-cell treatment for people with advanced dry age-related macular degeneration (AMD), a condition that causes blurring or loss of central vision. It aims to replace damaged cells in the back of the eye to potentially slow vision loss and improve day-to-day sight.
This study looks at how different types of lighting (like bright or dim lights) affect your ability to see if you have dry AMD. The goal is to find lighting conditions that help you see better, which could improve your daily life.
This study is testing whether shining a special light on the eye, called photobiomodulation, can help people with dry age-related macular degeneration (AMD). If you have dry AMD and are willing to participate, you will receive the light treatment and be monitored.
This study tests a light-based therapy called photobiomodulation for dry age-related macular degeneration (AMD). It aims to see if this treatment can help preserve vision in the dry AMD eye, and includes people who have dry AMD in one eye and wet AMD in the other.
This trial tests a new type of electrical stimulation, called microcurrent therapy, to see if it can help people with a certain form of age-related macular degeneration (AMD) that is not the "wet" kind. The treatment is delivered through an eye patch-like device and may slow vision loss or improve function.
Hear when a new AMD - Age-Related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.